Skip to main content

Published locations for FDA approves Zolgensma for infantile-onset SMA treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves Zolgensma for infantile-onset SMA treatment

User login

  • Reset your password
  • /content/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /clinicianreviews/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /familypracticenews/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /neurologyreviews/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /pediatricnews/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /jcomjournal/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /pediatrics/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /neurology/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /familymedicine/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment
  • /clinicalneurologynews/article/201640/neurology/fda-approves-zolgensma-infantile-onset-sma-treatment